Published in J Biol Chem on November 24, 1995
Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. Proc Natl Acad Sci U S A (1996) 1.57
Regulation of murine cystic fibrosis transmembrane conductance regulator Cl- channels expressed in Chinese hamster ovary cells. J Physiol (1998) 1.13
Comparison of the gating behaviour of human and murine cystic fibrosis transmembrane conductance regulator Cl- channels expressed in mammalian cells. J Physiol (1998) 1.10
Slow conversions among subconductance states of cystic fibrosis transmembrane conductance regulator chloride channel. Biophys J (1996) 0.97
Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein. J Bioenerg Biomembr (1997) 0.94
Cysteine residues in the nucleotide binding domains regulate the conductance state of CFTR channels. Biophys J (2002) 0.89
Expression and function of human MRP1 (ABCC1) is dependent on amino acids in cytoplasmic loop 5 and its interface with nucleotide binding domain 2. J Biol Chem (2010) 0.88
Conformation, independent of charge, in the R domain affects cystic fibrosis transmembrane conductance regulator channel openings. Biophys J (2000) 0.87
The cystic fibrosis gene: a molecular genetic perspective. Cold Spring Harb Perspect Med (2013) 0.81
Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages. Autophagy (2016) 0.79
Molecular and functional characterization of the cystic fibrosis transmembrane conductance regulator from the Australian common brushtail possum, Trichosurus vulpecula. J Comp Physiol B (2009) 0.77
The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closing. Cell Physiol Biochem (2010) 0.76
Rectification of cystic fibrosis transmembrane conductance regulator chloride channel mediated by extracellular divalent cations. Biophys J (1996) 0.76
CHARMM: the biomolecular simulation program. J Comput Chem (2009) 27.71
Identification of the cystic fibrosis gene: chromosome walking and jumping. Science (1989) 21.46
An STS-based map of the human genome. Science (1995) 17.72
GAL4-VP16 is an unusually potent transcriptional activator. Nature (1988) 16.53
A gene map of the human genome. Science (1996) 14.32
Deletion analysis of GAL4 defines two transcriptional activating segments. Cell (1987) 14.13
A physical map of 30,000 human genes. Science (1998) 12.43
Highly pathogenic H5N1 influenza virus infection in migratory birds. Science (2005) 9.64
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50
Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med (1995) 4.82
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood (1997) 4.78
Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst (1996) 4.66
Purified ryanodine receptor from rabbit skeletal muscle is the calcium-release channel of sarcoplasmic reticulum. J Gen Physiol (1988) 4.56
The carboxy-terminal 30 amino acids of GAL4 are recognized by GAL80. Cell (1987) 4.49
Construction of a general human chromosome jumping library, with application to cystic fibrosis. Science (1987) 3.87
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature (1997) 3.74
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA (1996) 3.69
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood (1997) 3.56
Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature. Am J Med (1979) 3.54
Generating yeast transcriptional activators containing no yeast protein sequences. Nature (1991) 3.21
Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J Biol Chem (1993) 3.02
The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging (1992) 2.97
A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci (1999) 2.92
Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab (1996) 2.78
Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr (2001) 2.64
Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res (2011) 2.64
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
The superfamily of heme-copper respiratory oxidases. J Bacteriol (1994) 2.57
Joint estimation of water/fat images and field inhomogeneity map. Magn Reson Med (2008) 2.35
Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res (1999) 2.30
Research in cystic fibrosis (third of three parts). N Engl J Med (1976) 2.29
Prevalence of cryptosporidiosis in patients undergoing endoscopy: evidence for an asymptomatic carrier state. Am J Med (1989) 2.21
An HMG-like protein that can switch a transcriptional activator to a repressor. Nature (1994) 2.18
Surveillance of the first case of human avian influenza A (H7N9) virus in Beijing, China. Infection (2013) 2.18
Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol (1995) 2.11
Smoking cessation in China: findings from the 1996 national prevalence survey. Tob Control (2001) 2.10
Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest (1997) 2.10
Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis (1999) 2.06
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet (1998) 1.96
Characterization of short tandem repeats from thirty-one human telomeres. Genome Res (1997) 1.96
An allosteric model of the molecular interactions of excitation-contraction coupling in skeletal muscle. J Gen Physiol (1993) 1.83
TSF3, a global regulatory protein that silences transcription of yeast GAL genes, also mediates repression by alpha 2 repressor and is identical to SIN4. Mol Cell Biol (1993) 1.82
A colon cancer cell line (LIM1215) derived from a patient with inherited nonpolyposis colorectal cancer. J Natl Cancer Inst (1985) 1.79
Printable thin film supercapacitors using single-walled carbon nanotubes. Nano Lett (2009) 1.79
Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells. J Biol Chem (1999) 1.75
Prostate cancer incidence and mortality in the United States and the United Kingdom. J Natl Cancer Inst (1998) 1.74
Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest (1998) 1.71
High prevalence of bla(CTX-M) extended-spectrum β-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect (2010) 1.70
Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol (1990) 1.69
Research in cystic fibrosis (second of three parts). N Engl J Med (1976) 1.66
Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J Inorg Biochem (2003) 1.66
Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell (1997) 1.60
The Drosophila morphogenetic protein Bicoid binds DNA cooperatively. Development (1996) 1.59
Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am J Physiol Lung Cell Mol Physiol (2001) 1.59
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett (2001) 1.58
3849+10 kb C-->T mutation and disease severity in cystic fibrosis. Lancet (1995) 1.57
Drilling the posterior wall of the petrous pyramid: a microneurosurgical anatomical study. J Neurosurg (1993) 1.57
Developmental regulation of heterochromatin-mediated gene silencing in Drosophila. Development (1998) 1.56
Functional calcium release channel formed by the carboxyl-terminal portion of ryanodine receptor. Biophys J (1997) 1.55
MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene (2012) 1.55
Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell (1999) 1.54
Opposing regulatory functions of positive and negative elements in UASG control transcription of the yeast GAL genes. Mol Cell Biol (1990) 1.53
Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab (2001) 1.53
Research in cystic fibrosis (first of three parts). N Engl J Med (1976) 1.52
Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. Am J Respir Crit Care Med (2000) 1.52
Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer (1999) 1.50
Cognitive screening tests: an aid in the care of elderly outpatients. J Gen Intern Med (1990) 1.50
Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies. Pain (2008) 1.49
Insight into the active-site structure and function of cytochrome oxidase by analysis of site-directed mutants of bacterial cytochrome aa3 and cytochrome bo. J Bioenerg Biomembr (1993) 1.49
The missing link between thermodynamics and structure in F1-ATPase. Proc Natl Acad Sci U S A (2003) 1.48
The asp-rich region at the carboxyl-terminus of calsequestrin binds to Ca(2+) and interacts with triadin. FEBS Lett (2000) 1.48
INFORMAS (International Network for Food and Obesity/non-communicable diseases Research, Monitoring and Action Support): overview and key principles. Obes Rev (2013) 1.46
Relationship between complaints and quality of care in New Zealand: a descriptive analysis of complainants and non-complainants following adverse events. Qual Saf Health Care (2006) 1.46
Giant anharmonic phonon scattering in PbTe. Nat Mater (2011) 1.45
Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer. Eur J Surg Oncol (2010) 1.42
Cancellous bone volume and structure in the forearm: noninvasive assessment with MR microimaging and image processing. Radiology (1998) 1.42
Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res (2001) 1.40
Rescue of bicoid mutant Drosophila embryos by bicoid fusion proteins containing heterologous activating sequences. Nature (1989) 1.40
Local Thermal Fixing of a Photorefractive LiNbO(3) Hologram by use of a CO(2) Laser. Appl Opt (1998) 1.39
Drosophila ELL is associated with actively elongating RNA polymerase II on transcriptionally active sites in vivo. EMBO J (2001) 1.39
Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev (1999) 1.37
Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev (1996) 1.36
Mortality and social class in New Zealand. I: overall male mortality. N Z Med J (1983) 1.36
No strict alignment is required between a transcriptional activator binding site and the "TATA box" of a yeast gene. Proc Natl Acad Sci U S A (1988) 1.35
Virulence properties and protective efficacy of the capsular polymer of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5. Infect Immun (1988) 1.35
Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J Biol Chem (2001) 1.35
Dietary changes improve survival of CFTR S489X homozygous mutant mouse. Am J Physiol (1995) 1.34
Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, double-blind, active control trial(*). Diabetes Obes Metab (2011) 1.33
Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res (1994) 1.33
The organic component of diesel exhaust particles and phenanthrene, a major polyaromatic hydrocarbon constituent, enhances IgE production by IgE-secreting EBV-transformed human B cells in vitro. Toxicol Appl Pharmacol (1997) 1.33
Heritable alteration in DNA methylation induced by nitrogen-deficiency stress accompanies enhanced tolerance by progenies to the stress in rice (Oryza sativa L.). J Plant Physiol (2011) 1.33
Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol (1999) 1.31
Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore. Biophys J (1998) 1.30
A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Oncol Biol Phys (1994) 1.30
Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med (2001) 1.30
A review. Cystic fibrosis at forty--quo vadis? Pediatr Res (1980) 1.27